Developing a novel FRET assay, targeting the binding between Antizyme-AZIN

Aram Ghalali1, James M Rice1,2, Amanda Kusztos1,3

  • 1Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Scientific Reports
|March 16, 2019
PubMed
Summary

Researchers developed a novel FRET sensor to measure antizyme-AZIN protein interactions, crucial for cell cycle regulation. This tool enables high-throughput screening for potential drug targets impacting cell proliferation.